Modernizing Pharmaceutical Manufacturing

FDA's Center for Drug Evaluation and Research is driving efforts toward creating initiatives to streamline regulatory processes, speed up drug production, and reduce costs.

Related Content:

Quality SystemsRegulatory WatchPharmaceutical Technology-02-02-2002

Using Continuous Processes and Automation to Remove Contamination Risk

Takeda Receives Japanese Regulatory Approval for HYQVIA Subcutaneous Injection for Treating Agammaglobulinemia or Hypogammaglobulinemia

FDA Releases Draft Guidance on Sampling and Testing of In-Process Materials and Drug Products